Date

Tuesday, 10 June 2025

Place

Sinarmas MSIG Tower, 37th Floor Unit 102 & 106 Jl. Jend. Sudirman Kav. 21 Seti

Time

10:00 WIB

Jadwal acara

RUPST

  1. Approval of the Company's Annual Report from the Board of Directors, covering business activities and financial administration for the financial year ending 31 December 2024, as well as ratification of the Balance Sheet and Profit and Loss Statement for the financial year ending 31 December 2024, including granting full discharge and release of responsibility (acquit et de charge) to the members of the Board of Directors and the Board of Commissioners for management and supervisory actions undertaken during the financial year.

  2. Approval of the allocation of the Company's net profit for the financial year ending 31 December 2024.

  3. Approval of the appointment of a Public Accounting Firm to audit the Company's Financial Statements for the financial year ending 31 December 2025, along with determination of the honorarium for the appointed firm.

  4. Approval of the determination of salaries and other allowances for the Board of Directors and the Board of Commissioners for the period January to December 2025.

  5. Approval of changes to the Company's Board of Directors.

SCPI - PT. Organon Pharma Indonesia Tbk

Rp 0

0 (0%)